4.5 Article

Alcohol abuse and smoking alter inflammatory mediator production by pulmonary and systemic immune cells

Publisher

AMER PHYSIOLOGICAL SOC
DOI: 10.1152/ajplung.00242.2015

Keywords

mononuclear cells; oxidative stress; pathogen-associated molecular patterns; smoking

Funding

  1. National Institutes of Health [R24 AA-019661, UL1 TR-001082]
  2. University of Colorado Department of Medicine

Ask authors/readers for more resources

Alcohol use disorders (AUDs) and tobacco smoking are associated with an increased predisposition for community-acquired pneumonia and the acute respiratory distress syndrome. Mechanisms are incompletely established but may include alterations in response to pathogens by immune cells, including alveolar macrophages (AMs) and peripheral blood mononuclear cells (PBMCs). We sought to determine the relationship of AUDs and smoking to expression of IFN gamma, IL-1 beta, IL-6, and TNF alpha by AMs and PBMCs from human subjects after stimulation with lipopolysaccharide (LPS) or lipoteichoic acid (LTA). AMs and PBMCs from healthy subjects with AUDs and controls, matched on smoking, were cultured with LPS (1 mu g/ml) or LTA (5 mu g/ml) in the presence and absence of the antioxidant precursor N-acetylcysteine (10 mM). Cytokines were measured in cell culture supernatants. Expression of IFN gamma, IL-1 beta, IL-6, and TNF alpha in AMs and PBMCs was significantly increased in response to stimulation with LPS and LTA. AUDs were associated with augmented production of proinflammatory cytokines, particularly IFN gamma and IL-1 beta, by AMs and PBMCs in response to LPS. Smoking diminished the impact of AUDs on AM cytokine expression. Expression of basal AM and PBMC Toll-like receptors-2 and -4 was not clearly related to differences in cytokine expression; however, addition of N-acetylcysteine with LPS or LTA led to diminished AM and PBMC cytokine secretion, especially among current smokers. Our findings suggest that AM and PBMC immune cell responses to LPS and LTA are influenced by AUDs and smoking through mechanisms that may include alterations in cellular oxidative stress.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Surgery

Internal and External Validation of an Alcohol Biomarker for Screening in Trauma

Majid Afshar, Kenneth Baker, Josefine Corral, Erin Ross, Erin Lowery, Richard Gonzalez, Ellen L. Burnham, Rachael A. Callcut, Lucy Z. Kornblith, Carolyn Hendrickson, Elizabeth J. Kovacs, Cara Joyce

Summary: This study aimed to examine biomarkers for screening unhealthy alcohol use in the trauma setting. It found that PEth alone was the best biomarker, performing better than existing screening systems with blood alcohol concentration (BAC).

ANNALS OF SURGERY (2022)

Article Critical Care Medicine

Association Between Vasopressin Rebranding and Utilization in Patients With Septic Shock

Gretchen L. Sacha, Tyree H. Kiser, Garth C. Wright, R. William Vandivier, Marc Moss, Ellen L. Burnham, P. Michael Ho, Paul M. Reynolds, Seth R. Bauer

Summary: This study aimed to examine the impact of the rebranding of vasopressin on its utilization in patients with severe sepsis or septic shock. The results showed that the utilization of vasopressin continued to increase quarterly after the rebranding, despite a significant increase in its cost. This suggests that patients with septic shock have an inelastic demand for vasopressin.

CRITICAL CARE MEDICINE (2022)

Article Critical Care Medicine

Age and Injury Size Influence the Magnitude of Fecal Dysbiosis in Adult Burn Patients

Kiran Dyamenahalli, Kevin Choy, Daniel N. Frank, Kevin Najarro, Devin Boe, Kathryn L. Colborn, Juan-Pablo Idrovo, Anne L. Wagner, Arek J. Wiktor, Majid Afshar, Ellen L. Burnham, Rachel H. McMahan, Elizabeth J. Kovacs

Summary: Clinical studies have shown that age 50 years or older is an independent risk factor for poor prognosis after burn injury. Changes in the intestinal microbiome may contribute to the heightened systemic response seen in aging burn patients. This study found significant differences in the fecal microbiome between older burn patients and those with larger burn areas, which may be associated with immune system dysregulation and worsened clinical outcomes.

JOURNAL OF BURN CARE & RESEARCH (2022)

Letter Biochemistry & Molecular Biology

Clinical trial design during and beyond the pandemic: the I-SPY COVID trial

Carolyn S. Calfee, Kathleen D. Liu, Adam L. Asare, Jeremy R. Beitler, Paul A. Berger, Melissa H. Coleman, Alessio Crippa, Andrea Discacciati, Martin Eklund, Daniel C. Files, Sheetal Gandotra, Kevin W. Gibbs, Paul Henderson, Joseph E. Levitt, Ruixiao Lu, Michael A. Matthay, Nuala J. Meyer, Derek W. Russell, Karl W. Thomas, Laura J. Esserman, Aaron M. Mittel, Amy L. Dzierba, Purnema Madahar, Alexis L. Serra, Amanda Rosen, Ivan Garcia, Justin Muir, John Schicchi, Anita Darmanian, Romina Wahab, Katarzyna Gosek, Sara C. Auld, Max W. Adelman, Katherine L. Nugent, Gavin H. Harris, Christina Creel-Bulos, Philip Yang, Joshua F. Detelich, Christine Spainhour, Nathan K. Cobb, Rajiv Sonti, Lindsey A. Orr, Philip A. Robinson, Farjad Sarafian, Esmeralda Martinez, Patrice Jones, Julie Nguyen, Timothy F. Obermiller, Bethany Weiler-Lisowski, Lucia Kufa, Paul L. Saba, Jaime Wyatt, Fady A. Youssef, Maged Tanios, Daniel Blevins, Laura R. Macias, Alexis E. Suarez, Maria B. Reyes, Michelle Jung, Marylee Melendrez, Lissette Rosario-Remigio, Henry Su, Eliot B. Friedman, Christina M. Angelucci, Fredy Chaparro-Rojas, Mitchell P. Sternlieb, Jacqueline B. Sutter, Spencer Whealon, Rahul Nair, Brenda Lopez, Omowunmi Amosu, Hiwet Tzehaie, Richard G. Wunderink, Chirag Patel, Austin Simonson, Jamal Dodin, Tony Oliver, Roxana A. Lupu, Michelle Meyers, Timothy E. Albertson, Angela Haczku, Erin Hardy, Brian M. Morrissey, Maya M. Juarez, Skyler J. Pearson, Richard Anthony Lee, Alpesh N. Amin, Alejandra Jauregui, Scott Fields, Diana Ng, Brian M. Daniel, Kimberly Yee, Chayse Jones, Ellen L. Burnham, Jeffrey D. McKeehan, Caroline A. G. Ittner, John P. Reilly, Nilam S. Mangalmurti, Laura G. Rodrigues, Ariel R. Weisman, Kashif T. Khan, Se Fum Wong, Albert F. Yen, Gregory Peterfreund, Santhi I. Kumar, Peter S. Marshall, Luis E. Huerta, Brett Lindgren, Jerry S. Lee, Anna D. Barker, Julie E. Lang, Mary LaRose, Leigha Landreth, Lisa Parks, Harsh V. Barot, Jonathan L. Koff, John Kazianis, Lindsie L. Boerger

NATURE MEDICINE (2022)

Article Substance Abuse

COVID-19 patients with documented alcohol use disorder or alcohol-related complications are more likely to be hospitalized and have higher all-cause mortality

Kristina L. Bailey, Harlan Sayles, James Campbell, Neha Khalid, Madyson Anglim, Jana Ponce, Todd A. Wyatt, James C. McClay, Ellen L. Burnham, Alfred Anzalone, Corrine Hanson

Summary: This study reveals that alcohol use disorder (AUD) may increase the severity and mortality of COVID-19 infection. This emphasizes the importance for clinicians to obtain accurate alcohol history from patients hospitalized with COVID-19.

ALCOHOL-CLINICAL AND EXPERIMENTAL RESEARCH (2022)

Article Urology & Nephrology

Kidney Recovery and Death in Critically Ill Patients With COVID-19-Associated Acute Kidney Injury Treated With Dialysis: The STOP-COVID Cohort Study

Caroline M. Hsu, Shruti Gupta, Hocine Tighiouart, Nitender Goyal, Anthony J. Faugno, Asma Tariq, Ritesh Raichoudhury, Jill H. Sharma, Leah Meyer, Ravi K. Kshirsagar, Aju Jose, David E. Leaf, Daniel E. Weiner

Summary: This study examined the clinical factors that determine kidney recovery in critically ill patients with COVID-19. The results showed that lower baseline eGFR and reduced urine output at the time of kidney replacement therapy initiation are strongly associated with kidney nonrecovery.

AMERICAN JOURNAL OF KIDNEY DISEASES (2022)

Article Biochemistry & Molecular Biology

Aberrant Multiciliogenesis in Idiopathic Pulmonary Fibrosis

Eunjoo Kim, Susan K. Mathai, Ian T. Stancil, Xiaoqian Ma, Ashley Hernandez-Gutierrez, Jessica N. Becerra, Emilette Marrero-Torres, Corinne E. Hennessy, Kristina Hatakka, Eric P. Wartchow, Alani Estrella, Jonathan P. Huber, Jonathan H. Cardwell, Ellen L. Burnham, Yingze Zhang, Christopher M. Evans, Eszter K. Vladar, David A. Schwartz, Evgenia Dobrinskikh, Ivana Yang

Summary: This study demonstrates the association of increased expression of MUC5B and cilia genes in idiopathic pulmonary fibrosis (IPF) and shows that modulating cilium gene expression in Krt5 cell progenitors may be a potential therapeutic target for IPF.

AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2022)

Article Health Care Sciences & Services

Association of Women Leaders with Women Program Director and Trainee Representation Across US Academic Internal Medicine

Kantha Medepalli, Stefanie Purdon, Rebecca M. Bade, M. K. Glassberg, Ellen L. Burnham, Hayley B. Gershengorn

Summary: Women are underrepresented in leadership positions in academic internal medicine, and having women leaders is not independently associated with having more women trainees.

JOURNAL OF GENERAL INTERNAL MEDICINE (2023)

Article Medicine, General & Internal

I-SPY COVID adaptive platform trial for COVID-19 acute respiratory failure: rationale, design and operations

Daniel Clark Files, Michael A. Matthay, Carolyn S. Calfee, Neil R. Aggarwal, Adam L. Asare, Jeremy R. Beitler, Paul A. Berger, Ellen L. Burnham, George Cimino, Melissa H. Coleman, Alessio Crippa, Andrea Discacciati, Sheetal Gandotra, Kevin W. Gibbs, Paul T. Henderson, Caroline A. G. Ittner, Alejandra Jauregui, Kashif T. Khan, Jonathan L. Koff, Julie Lang, Mary LaRose, Joe Levitt, Ruixiao Lu, Jeffrey D. McKeehan, Nuala J. Meyer, Derek W. Russell, Karl W. Thomas, Martin Eklund, Laura J. Esserman, Kathleen D. Liu

Summary: The ISPY COVID-19 trial is a multicenter open-label phase 2 platform trial designed to evaluate therapeutics for severe COVID-19. The trial uses a Bayesian model to efficiently discard ineffective therapies and graduate promising agents for further efficacy trials. As of December 2021, 11 investigational agent arms had been activated, and 8 arms were complete.

BMJ OPEN (2022)

Article Critical Care Medicine

Extracorporeal Membrane Oxygenation for Refractory Asthma Exacerbations With Respiratory Failure

Jonathan K. Zakrajsek, Sung -Joon Min, P. Michael Ho, Tyree H. Kiser, Arun Kannappan, Peter D. Sottile, Richard R. Allen, Meghan D. Althoff, Paul M. Reynolds, Marc Moss, Ellen L. Burnham, Mark E. Mikkelsen, R. William Vandivier

Summary: This retrospective cohort study analyzed 13,714 patients with asthma exacerbations and respiratory failure, including 127 treated with ECMO and 13,587 without ECMO. The results showed that ECMO treatment was associated with lower mortality but higher hospital costs compared to standard care. These findings suggest that ECMO may be an important salvage therapy for refractory asthma exacerbations with respiratory failure.

CHEST (2023)

Article Critical Care Medicine

Wellness and Coping of Physicians Who Worked in ICUs During the Pandemic: A Multicenter Cross-Sectional North American Survey

Karen E. A. Burns, Marc Moss, Edmund Lorens, Elizabeth Karin Ann Jose, Claudio M. Martin, Elizabeth M. Viglianti, Alison Fox-Robichaud, Kusum S. Mathews, Kathleen Akgun, Snigdha Jain, Hayley Gershengorn, Sangeeta Mehta, Jenny E. Han, Gregory S. Martin, Janice M. Liebler, Renee D. Stapleton, Polina Trachuk, Kelly C. Vranas, Abigail Chua, Margaret S. Herridge, Jennifer L. Y. Tsang, Michelle Biehl, Ellen L. Burnham, Jen-Ting Chen, Engi F. Attia, Amira Mohamed, Michelle S. Harkins, Sheryll M. Soriano, Aline Maddux, Julia C. West, Andrew R. Badke, Sean M. Bagshaw, Alexandra Binnie, W. Graham Carlos, Basak Coruh, Kristina Crothers, Frederick D'Aragon, Joshua Lee Denson, John W. Drover, Gregg Eschun, Anna Geagea, Donald Griesdale, Rachel Hadler, Jennifer Hancock, Jovan Hasmatali, Bhavika Kaul, Meeta Prasad Kerlin, Rachel Kohn, D. James Kutsogiannis, Scott M. Matson, Peter E. Morris, Bojan Paunovic, Ithan D. Peltan, Dominique Piquette, Mina Pirzadeh, Krishna Pulchan, Lynn M. Schnapp, Curtis N. Sessler, Heather Smith, Eric Sy, Subarna Thirugnanam, Rachel K. McDonald, Katie A. McPherson, Monica Kraft, Michelle Spiegel, Peter M. Dodek

Summary: This study examined physician moral distress, burnout, and professional fulfilment during the COVID-19 pandemic and identified important factors related to physician wellness. Despite widespread moral distress and burnout among physicians during the pandemic, professional fulfilment remained moderate. However, one in five physicians used maladaptive coping strategies.

CRITICAL CARE MEDICINE (2022)

Article Substance Abuse

Aberrant inflammatory responses in intoxicated burn-injured patients parallel impaired cognitive function

Kevin Choy, Kiran U. Dyamenahalli, Shanawaj Khair, Kathryn L. Colborn, Arek J. Wiktor, Juan -Pablo Idrovo, Rachel H. McMahan, Ellen L. Burnham, Elizabeth J. Kovacs

Summary: Burn-injured patients with alcohol use disorder have higher morbidity and mortality rates compared to alcohol-abstaining individuals due to alcohol-induced dysregulation of the systemic inflammatory response, leading to worsened clinical outcomes. The study examined the effects of alcohol on inflammatory markers after burn injury and found that patients who misuse alcohol have aberrant inflammatory responses, which may result in immune dysregulation and worse clinical outcomes.

ALCOHOL (2023)

Article Medicine, General & Internal

Report of the first seven agents in the I-SPY COVID trial: a phase 2, open label, adaptive platform randomised controlled trial

D. Clark Files

Summary: An adaptive platform design was used to rapidly evaluate potential therapeutics for severe COVID-19. The study included hospitalized patients with severe COVID-19 and compared the outcomes of different treatment regimens. The results showed that none of the evaluated agents met the pre-specified efficacy criteria.

ECLINICALMEDICINE (2023)

Article Respiratory System

Association between Substance Misuse and Outcomes in Critically III Patients with Pneumonia

Paul M. Reynolds, Majid Afshar, Garth C. Wright, P. Michael Ho, Tyree H. Kiser, Peter D. Sottile, Meghan D. Althoff, Marc Moss, Sarah E. Jolley, R. William Vandivier, Ellen L. Burnham

Summary: In patients with pneumonia requiring ICU admission, alcohol and stimulant misuse are associated with increased mortality, while other substance misuse does not have a significant impact on mortality.

ANNALS OF THE AMERICAN THORACIC SOCIETY (2023)

Letter Biochemistry & Molecular Biology

Chronic Marijuana Use Is Associated with Gene Expression Changes in BAL

Cuining Liu, Jeanette Gaydos, Rebecca Johnson-Paben, Katerina Kechris, Ellen L. Burnham, Sunita Sharma

AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2022)

No Data Available